Daewoong Pharm to jump into domestic anticancer market

Daewoong Pharm said on March 15 that it signed an exclusive agreement with U.K.-based BiolitecAG for the distribution of Foscan, which is a photosensitizing agent containing temoporfin and is used in photodynamic therapy (PDT). It added that in the latter half of this year, Daewoong will roll out another angicancer leuporlide through the establishment of its Task Force Team.

The local market...